Dr. David M. Aboulafia, MD

  • Seattle, WA
  • Hematologist and oncologist
NPI1043269392PAC ID6406740943
Medicare services, 2024
1,715
Medicare patients, 2024
445
Part D claims, 2024
4,581
Publications
58
Clinical trials
11
Practice address
1100 9th Ave, Seattle, WA 98101
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Virginia Mason Medical Center - HOPD

Acute Care Hospital outpatient department · Seattle, Washington

See all 13 affiliations

Find Dr. Aboulafia's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David M. Aboulafia is a hematologist and oncologist in Seattle, Washington

Dr. Aboulafia practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Aboulafia's NPI, 1043269392, was assigned on May 6, 2006. Dr. Aboulafia graduated from University of Michigan Medical School in 1983. Dr. Aboulafia holds Washington license MD00027799.

NPI and contact details
Medicare PAC ID
6406740943
NPI enumeration date
May 6, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
69
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. David M. Aboulafia practices at Virginia Mason Medical Center - HOPD in Seattle, Washington

Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

  • Virginia Mason Medical Center - HOPD
    1100 9th Ave, Seattle, WA 98101

Source: Dmand AI Affiliation Data

Dr. David M. Aboulafia is affiliated with 10 sites of care and 3 medical groups

Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Aboulafia is also affiliated with Virginia Mason Medical Center. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Aboulafia to 4 more hospitals, 3 group practices and clinics, 2 medical groups and 1 imaging center, each named with a free account. Dr. Aboulafia's employer is on file too: a hospital.

See all 13 affiliations for Dr. Aboulafia

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. David M. Aboulafia's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aboulafia practices, 10 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Virginia Mason Medical Center - HOPDAvailable with a free account
+9 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Aboulafia practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David M. Aboulafia is one of 348 hematologists and oncologists in Washington

Hematology and oncology is Dr. Aboulafia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Aboulafia is licensed in Washington.

Specialties and state licenses

  • Hematology and oncology, WashingtonPrimaryLicense MD00027799 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Aboulafia

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David M. Aboulafia billed Medicare for 1,715 services in 2024

CMS data shows 1,715 Medicare services from Dr. Aboulafia across 10 procedure codes in 2024, for 445 Medicare patients. Medicare paid $121,103 for them.

Medicare services, 20241,715
Medicare patients445
Paid by Medicare$121,103
Procedure codes10

Dr. Aboulafia's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,5772024: 1,28119%
Surgery
2023: 5192024: 41620%
Lab and pathology
2023: 772024: 1877%

Where Dr. Aboulafia's Medicare services took place, 2024

  • In an office87251%
  • In a facility84349%

Dr. Aboulafia compared with the Washington median for hematologists and oncologists, 2024

  • Dr. Aboulafia
  • Washington median
Medicare services
1,715vs 5852.9 times
Medicare patients
445vs 1822.4 times
Part D claims
4,066vs 28314.4 times

Medians across 310 hematologists and oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Aboulafia's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Aboulafia

Need commercial claims for Dr. Aboulafia?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Aboulafia and other hematologists and oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. David M. Aboulafia treated 445 Medicare patients in 2024, average age 75

CMS counts 445 Medicare patients who saw Dr. Aboulafia in 2024. The largest group is 75 to 84, with 184 patients. 61% of them have high blood pressure, and 61% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aboulafia's median patient age at 73, with 42% women.

Medicare patients, 2024445
Average age75
Average risk score1.74
Also on Medicaid11%

Dr. Aboulafia's Medicare patients by age, 2024

Dr. Aboulafia's Medicare patients by sex, 2024

  • Women17239%
  • Men27361%

Chronic conditions among Dr. Aboulafia's Medicare patients, 2024

  1. High blood pressure61%
  2. High cholesterol61%
  3. Arthritis41%
  4. Ischemic heart disease26%
  5. Cancer24%
  6. Chronic kidney disease24%
  7. Diabetes23%
  8. Atrial fibrillation22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Aboulafia's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women42%
  • Men58%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. David M. Aboulafia wrote 4,581 Medicare Part D claims in 2024

In 2024, Dr. Aboulafia wrote 4,581 Medicare Part D claims for 297 patients. 63% of them were for generic drugs. CMS names the drug for 4,066 of them, across 107 drugs with 11 or more claims each, at $9,095,416 in total drug cost. In 2023, CMS named 4,475 claims across 116 drugs.

Part D claims, 20244,581
Drugs named by CMS107
Total drug cost$9.1M
Part D patients297

Dr. Aboulafia's Part D claims by kind of drug, 2024

  • Generic2,885 claims63%
  • Brand-name1,682 claims37%
  • Other14 claims0%

Dr. Aboulafia's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Aboulafia's Part D claims, 2024

  • Opioids4%186 of 4,581 claims
  • Antibiotics1%44 of 4,581 claims
  • Antipsychotics, patients 65 and over0%15 of 4,581 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4,4752024: 4,0669%

Drugs named by CMS: 107 in 2024, 116 in 2023.

See all prescribing by Dr. Aboulafia

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. David M. Aboulafia offers telehealth to Medicare patients

Dr. Aboulafia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aboulafia as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Aboulafia by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David M. Aboulafia has 58 publications on record

Dmand AI links 58 papers to Dr. Aboulafia, published from 2010 to 2025. 2018 was the busiest year, with 6. The most frequent topics are HIV Infections, Acquired Immunodeficiency Syndrome and Anus Neoplasms. Dr. Aboulafia has published most often in Clin Med Insights Blood Disord. Dr. Aboulafia's most frequent co-authors are Prakash Vishnu, MBBS, MD, Ronald Takeshi Mitsuyasu, MD and Joel M. Palefsky, MD.

Papers58
Years published2010 to 2025

Dr. Aboulafia's papers by year, 2016 to 2025

Topics Dr. Aboulafia writes about most

  • HIV Infections
  • Acquired Immunodeficiency Syndrome
  • Anus Neoplasms
  • Papillomavirus Infections
  • Polyethylene Glycols
  • Antiretroviral Therapy, Highly Active
  • Breast Neoplasms
  • Early Detection of Cancer

Dr. Aboulafia's most frequent co-authors

Recent publications by Dr. Aboulafia

See all 58 publications and co-authors

See who Dr. Aboulafia researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Aboulafia works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David M. Aboulafia has worked on 11 clinical trials

Dmand AI links Dr. Aboulafia to 11 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Squamous Intraepithelial Lesions, Anus Neoplasms and Morphological and Microscopic Findings. AIDS Malignancy Consortium sponsors the most, 5. Open Payments lists research payments to Dr. Aboulafia that name 2 trials.

Clinical trials with Dr. Aboulafia by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 1/2: 1 trial
  3. 3Phase 2: 3 trials
  4. 2Phase 3: 2 trials
  5. NonePhase 4: no trials

Conditions in Dr. Aboulafia's trials

  • Squamous Intraepithelial Lesions
  • Anus Neoplasms
  • Morphological and Microscopic Findings
  • Anal Canal Carcinoma
  • Atypical Hemolytic Uremic Syndrome

Investigators on the most trials with Dr. Aboulafia

Recent clinical trials with Dr. Aboulafia

See all 11 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. David M. Aboulafia received $47,265 in industry payments from 2016 to 2025

CMS Open Payments shows 78 general payments to Dr. Aboulafia from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Gilead Sciences, Inc. paid the most, $14,926. It also lists 4 research payments totaling $57,685 from 2017 to 2019, naming 2 clinical trials.

General payments to Dr. Aboulafia by program year, 2016 to 2025

General payments to Dr. Aboulafia by kind, 2016 to 2025

$47.3Kin total
  • Consulting fees$31,51167%
  • Honoraria$6,00013%
  • Travel and lodging$4,83710%
  • Speaker and faculty fees$3,0006%
  • Other$1,9174%

Companies that paid Dr. Aboulafia the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Aboulafia

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. David M. Aboulafia graduated from University of Michigan Medical School

Dr. Aboulafia graduated from University of Michigan Medical School in 1983.

  1. Medical schoolUniversity of Michigan Medical School

Source: Dmand AI Professional Profile Data

Sources for Dr. David M. Aboulafia's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David M. Aboulafia

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David M. Aboulafia's NPI number?

Dr. David M. Aboulafia's NPI number is 1043269392. It was assigned on May 6, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. David M. Aboulafia?

Dr. David M. Aboulafia is a hematologist and oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. David M. Aboulafia practice?

Dr. Aboulafia practices at 1100 9th Ave, Seattle, WA 98101. Dr. Aboulafia's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dmand AI also links Dr. Aboulafia to 4 hospitals, 3 group practices and clinics, 2 medical groups and 1 imaging center.

What is Dr. David M. Aboulafia's medical license number?

Dr. Aboulafia holds Washington license MD00027799.

Which hospitals is Dr. David M. Aboulafia affiliated with?

Dr. Aboulafia is affiliated with Virginia Mason Medical Center. Dmand AI links Dr. Aboulafia to 4 more hospitals.

What medical group is Dr. David M. Aboulafia part of?

Dr. Aboulafia is linked to Franciscan Orthopedics - Silverdale. Dmand AI links Dr. Aboulafia to 2 more medical groups.

Does Dr. David M. Aboulafia accept Medicare?

Yes. CMS data shows Dr. Aboulafia billed Medicare for 1,715 services in 2024, and Dr. Aboulafia accepts Medicare assignment.

Does Dr. David M. Aboulafia offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Aboulafia as offering telehealth services.

How many Medicare patients does Dr. David M. Aboulafia see?

CMS counts 445 Medicare patients who saw Dr. Aboulafia in 2024, with an average age of 75.

What services does Dr. David M. Aboulafia bill to Medicare?

In 2024, Dr. Aboulafia's most billed Medicare services were office visit, established patient (99214), surgery: heart and blood vessels (36415) and hospital inpatient care (99233).

Show 6 more questionsShow fewer questions

Where did Dr. David M. Aboulafia go to medical school?

Dr. Aboulafia graduated from University of Michigan Medical School in 1983.

What drugs does Dr. David M. Aboulafia prescribe most?

In 2024 Medicare Part D data, Dr. Aboulafia's most prescribed drugs by claims were Juluca, Atorvastatin Calcium and Hydroxyurea.

Has Dr. David M. Aboulafia received payments from drug or device companies?

CMS Open Payments shows $47,265 in general payments to Dr. Aboulafia from 14 companies from 2016 to 2025. The largest total came from Gilead Sciences, Inc.

How long has Dr. David M. Aboulafia been practicing?

Dr. Aboulafia graduated from medical school in 1983, 43 years ago.

Does Dr. David M. Aboulafia do research?

Dmand AI links 58 publications to Dr. Aboulafia, published from 2010 to 2025. Dr. Aboulafia has worked on 11 clinical trials.

Who does Dr. David M. Aboulafia publish with?

Dr. Aboulafia's most frequent co-authors are Prakash Vishnu, MBBS, MD (10 shared papers), Ronald Takeshi Mitsuyasu, MD (8 shared papers) and Joel M. Palefsky, MD (5 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)